Evidence map›Paper›PMID 40385361›Full record

ArticleNuclear medicine and molecular imaging2025

PET/CT Radiomics Integrated with Clinical Indexes as a Tool to Predict Ki67 in Breast Cancer: a Pilot Study.

Dawei Li, Hui Ding, Yuting Liao, Xiao Yu, Youmin Guo, Cong Shen

Abstract read
In one paragraph

Article in Nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dawei LiDepartment of Positron Emission Tomography/Computer Tomography, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi 710061 China.
Hui DingDepartment of Positron Emission Tomography/Computer Tomography, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi 710061 China.
Yuting LiaoClinical & Technical Support, Philips Healthcare, Shanghai, China.
Xiao YuClinical & Technical Support, Philips Healthcare, Shanghai, China.
Youmin GuoDepartment of Positron Emission Tomography/Computer Tomography, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi 710061 China.
Cong ShenDepartment of Positron Emission Tomography/Computer Tomography, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi 710061 China.ORCID https://orcid.org/0000-0001-5521-1612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to assess the value of radiomics features integrated with clinical characteristics for estimating Ki67 expression in patients with breast cancer (BC). Methods: In total, 114 patients with BC performed Results: The N stage, tumor morphology, SUVmax, and the longest diameter significantly differed between Ki67 + and Ki67- groups (all Conclusions: PET/CT image-based radiomics features combined with clinical features have the potential to predict Ki67 expression in BC. Supplementary Information: The online version contains supplementary material available at 10.1007/s13139-024-00896-9.

Indexed as

Breast cancerKi67PET/CTPredictive modelRadiomics

Identifiers

PMID40385361
PMCPMC12084439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.